Group 1 - The company expects a net profit attributable to shareholders for the fiscal year 2025 to be between 25 million to 35 million yuan, representing a year-on-year decline of 67.66% to 76.90% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 27 million to 37 million yuan, reflecting a year-on-year decrease of 65.11% to 74.54% [1] - The decline in performance is primarily attributed to intense market competition in the core sector of sexual health and a decrease in sales revenue [1] Group 2 - The core product "He Wei Zheng Chang Wan" is affected by insufficient production capacity and delays in imports [1] - Increased investment in research and development and brand promotion has led to a rise in selling expenses, thereby compressing profit margins [1]
泰恩康：预计2025年度实现净利润2500万元至3500万元，核心板块两性健康业务市场 竞争激烈导致销售收入有所下滑